The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122301353 12230135 3 F 201403 20160624 20160401 20160912 PER US-JNJFOC-20160303877 JANSSEN 53.85 YR A M Y 0.00000 20160912 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122301353 12230135 1 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 15 MG TABLET
122301353 12230135 2 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 15 MG TABLET
122301353 12230135 3 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 20 MG TABLET
122301353 12230135 4 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 15 MG TABLET
122301353 12230135 5 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 20 MG TABLET
122301353 12230135 6 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 20 MG TABLET
122301353 12230135 7 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 15 MG TABLET
122301353 12230135 8 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 20 MG TABLET
122301353 12230135 9 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 20 MG TABLET
122301353 12230135 10 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 15 MG TABLET
122301353 12230135 11 SS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 0 15 MG TABLET
122301353 12230135 12 PS XARELTO RIVAROXABAN 1 Oral Y U UNKNOWN;UNKNOWN 22406 20 MG TABLET
122301353 12230135 13 SS PLAVIX CLOPIDOGREL BISULFATE 1 Oral Y 0 75 MG TABLET
122301353 12230135 14 SS ASPIRIN. ASPIRIN 1 Oral Y 0 325 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122301353 12230135 1 Thrombosis prophylaxis
122301353 12230135 2 Thrombosis prophylaxis
122301353 12230135 3 Thrombosis prophylaxis
122301353 12230135 4 Thrombosis prophylaxis
122301353 12230135 5 Thrombosis prophylaxis
122301353 12230135 6 Thrombosis prophylaxis
122301353 12230135 7 Thrombosis prophylaxis
122301353 12230135 8 Thrombosis prophylaxis
122301353 12230135 9 Thrombosis prophylaxis
122301353 12230135 10 Thrombosis prophylaxis
122301353 12230135 11 Thrombosis prophylaxis
122301353 12230135 12 Thrombosis prophylaxis
122301353 12230135 13 Deep vein thrombosis
122301353 12230135 14 Deep vein thrombosis

Outcome of event

Event ID CASEID OUTC COD
122301353 12230135 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122301353 12230135 Dieulafoy's vascular malformation
122301353 12230135 Haematoma
122301353 12230135 Swelling
122301353 12230135 Upper gastrointestinal haemorrhage

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122301353 12230135 1 2014 201405 0
122301353 12230135 2 20140414 201404 0
122301353 12230135 3 20151119 0
122301353 12230135 4 20140212 201403 0
122301353 12230135 5 20140513 201412 0
122301353 12230135 6 20141217 201511 0
122301353 12230135 7 2014 201405 0
122301353 12230135 8 20151119 0
122301353 12230135 9 20141217 201511 0
122301353 12230135 10 20140414 201404 0
122301353 12230135 11 20140212 201403 0
122301353 12230135 12 20140513 201412 0
122301353 12230135 13 20140212 201404 0
122301353 12230135 14 201404 0